IDEXX Laboratories (IDXX) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alpha Teknova (TKNO) has outperformed IDEXX Laboratories (IDXX) over the past year, gaining 75.0% versus a loss of 17.6%. Over five years, IDXX leads with a -18.4% price change compared with -61.7% for TKNO. IDEXX Laboratories is the larger company by market cap ($40.81 billion vs $474.6 million), about 86.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IDXX | TKNO |
|---|---|---|
| Share price | $518.00 | $8.84 |
| Market cap | $40.81B | $474.60M |
| 1-day change | +0.95% | +4.74% |
| YTD return | -23.43% | +132.63% |
| 1-year return | -17.61% | +75.05% |
| 5-year return | -18.44% | -61.73% |
| P/E ratio (TTM) | 36.40 | — |
| Forward P/E | 30.95 | — |
| EPS (TTM) | $14.23 | $-0.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $4.30B | — |
| Revenue growth (YoY) | +10.42% | — |
| Net income (latest FY) | $1.06B | — |
| Gross margin | 61.80% | — |
| Operating margin | 31.60% | — |
| Net margin | 24.62% | — |
| 52-week high | $769.98 | $9.48 |
| 52-week low | $500.61 | $1.91 |
| Distance from 52-week high | -32.73% | -6.75% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +35.39% | +1.81% |
| Average volume | 553.95K | 234.74K |
| Shares outstanding | 78.78M | 53.69M |
| Employees | 11,000 | 158 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IDEXX Laboratories is about 86.0 times larger than Alpha Teknova by market value ($40.81B vs $474.60M).
- TKNO has outperformed IDXX by 92.7 percentage points over the past year.
About IDEXX Laboratories
IDXX stock →IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 11,000 employees
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 158 employees
IDXX vs TKNO FAQ
Which is bigger, IDEXX Laboratories or Alpha Teknova?
IDEXX Laboratories (IDXX) is larger, with a market capitalization of $40.81B compared with $474.60M for Alpha Teknova (TKNO).
Which stock has performed better over the past year, IDXX or TKNO?
TKNO returned +75.05% over the past 12 months, compared with -17.61% for IDXX (price return, excluding dividends). Past performance does not predict future results.
Are IDEXX Laboratories and Alpha Teknova in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.